The week in health tech, explained in plain English.Get the free newsletter →
October 29, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Government

Immigration Crackdown Drives Health Harms for Kids

Children in immigrant families are absorbing serious health consequences from the Trump administration's immigration enforcement, KFF Health News reports. The pressures include separation from parents detained or deported by Immigration and Customs Enforcement, economic and housing instability, and an environment of fear that keeps families from daily activities like school, work, and medical visits.

In practice, that fear is pushing families to withdraw from health and nutrition programs many of their children legally qualify for, including US-citizen kids. Skipping care and food assistance raises the odds of untreated illness, missed screenings, and developmental delays. Clinicians and researchers cited by KFF warn that chronic stress and disrupted caregiving can leave lasting marks on children's physical and mental health.

For health systems, payers, and public health agencies, the fallout lands downstream: sicker patients, more emergency care, and higher long-term costs when preventive services go unused. The pattern echoes the documented "chilling effect" of earlier immigration policies, now unfolding across a new generation of children.

More in Government

Government

Medicare Rule Could Cut Remote Patient Monitoring Access

A proposed CMS rule could sharply reduce Medicare reimbursement for remote patient monitoring, threatening access for rural and chronically ill patients.

Why it matters: Remote monitoring has become a fast-growing, loosely overseen Medicare service, and changing how it pays could reshape home-based care for millions.

Government

HHS Launches National Plan to Overhaul US Kidney Care

HHS launched a national kidney care plan centered on prevention, dialysis reform with more patient choice, and overhauling the transplant system.

Why it matters: Kidney disease affects 1 in 7 US adults and drives major Medicare spending, so federal direction here reshapes care models and markets.

Government

FDA Approves First Once-Weekly Insulin for Children

The FDA approved Novo Nordisk's Awiqli, the first once-weekly basal insulin for children 10 and older with Type 2 diabetes.

Why it matters: Weekly rather than daily insulin could improve adherence for a growing number of children with Type 2 diabetes.